CONFERENCE BILL: FY22
On March 15, 2022, President Biden signed into law H.R. 2471, a $1.5 trillion omnibus appropriations package that funds the government through September 30, 2022. The Senate passed the measure by a bipartisan vote of 68-31 on March 10, 2022, and the House approved it by a bipartisan vote of 260-171 on March 9, 2022. The law includes $650,797,00 for the Section 317 Immunization Program, an increase of more than $37 million from FY21.
The final Labor-HHS-Education appropriations bill was reduced by about $40 billion from the House bill, so many programs which previously saw increases in the House and Senate bills were either level funded or received very modest increases. The increase for the 317 Program demonstrates Congress’s continued interest in supporting immunization efforts across the country and enhancing adult immunization.
The conference bill includes the following legislative text relevant to the 317 Program:
IMMUNIZATION AND RESPIRATORY DISEASES
The agreement provides a total of $868,155,000 for Immunization and Respiratory Diseases, which includes $448,805,000 in discretionary appropriations and $419,350,000 in transfers from the PPH Fund. Within this total, the agreement includes the following amounts:
Budget Activity Section 317 Immunization Program: $650,797,000
Acute Flaccid Myelitis: $6,000,000
Influenza Planning and Response: $211,358,000
Enhancing Section 317 Immunization Program.—The agreement includes an increase to enhance adult immunization as directed in House Report 117-96. (By reference, the conference also includes the requirement for CDC to provide the annual report to Congress on the professional judgement budget for FY 2023 that has was advocated for by the 317 Coalition)
Improving Immunization Information Systems Infrastructure and Data.—The agreement directs CDC to provide an update to the Committees within 180 days of enactment of this Act on compliance with interoperability standards.
Influenza Planning and Response.—The agreement includes an increase to enhance CDC's influenza activities.